STOCK TITAN

Vanguard holds 2,875,190 Biohaven shares; 2.71% of class

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed an amended Schedule 13G reporting its beneficial ownership in Biohaven Ltd (BHVN). The filing states ownership of 2,875,190 shares, representing 2.71% of the company’s common stock as of 09/30/2025.

The filing details show sole voting power: 0 shares and shared voting power: 535,665 shares. Vanguard reports sole dispositive power: 2,228,799 shares and shared dispositive power: 646,391 shares. Vanguard is identified as an investment adviser (IA) and certifies the securities were acquired and are held in the ordinary course of business, not to change or influence control. Vanguard notes its clients have rights to dividends or sale proceeds, and no other person’s interest exceeds 5%.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:10/30/2025

FAQ

What ownership did The Vanguard Group report in BHVN?

Vanguard reported beneficial ownership of 2,875,190 shares, equal to 2.71% of Biohaven’s common stock as of 09/30/2025.

How much voting power did Vanguard report for BHVN?

Vanguard reported sole voting power: 0 shares and shared voting power: 535,665 shares.

What dispositive powers did Vanguard report for BHVN shares?

Vanguard reported sole dispositive power: 2,228,799 shares and shared dispositive power: 646,391 shares.

What type of reporting person is Vanguard on this filing?

Vanguard is identified as an Investment Adviser (IA) under Rule 13d-1(b)(1)(ii)(E).

What does Vanguard certify about its BHVN holdings?

Vanguard certifies the securities were acquired and are held in the ordinary course of business and not to change or influence control.

Who ultimately benefits from dividends or sale proceeds of these shares?

Vanguard states its clients, including registered investment companies and other managed accounts, have rights to dividends or sale proceeds; no single other person exceeds 5%.
Biohaven

NYSE:BHVN

View BHVN Stock Overview

BHVN Rankings

BHVN Latest News

BHVN Latest SEC Filings

BHVN Stock Data

1.34B
133.68M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN